Annual Revenue
$482.38 M
+$80.52 M+20.04%
December 31, 2023
Summary
- As of February 12, 2025, CORT annual revenue is $482.38 million, with the most recent change of +$80.52 million (+20.04%) on December 31, 2023.
- During the last 3 years, CORT annual revenue has risen by +$128.50 million (+36.31%).
- CORT annual revenue is now at all-time high.
Performance
CORT Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Revenue
$182.55 M
+$18.75 M+11.45%
September 30, 2024
Summary
- As of February 12, 2025, CORT quarterly revenue is $182.55 million, with the most recent change of +$18.75 million (+11.45%) on September 30, 2024.
- Over the past year, CORT quarterly revenue has increased by +$35.74 million (+24.34%).
- CORT quarterly revenue is now at all-time high.
Performance
CORT Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
TTM Revenue
$628.55 M
+$58.95 M+10.35%
September 30, 2024
Summary
- As of February 12, 2025, CORT TTM revenue is $628.55 million, with the most recent change of +$58.95 million (+10.35%) on September 30, 2024.
- Over the past year, CORT TTM revenue has increased by +$105.03 million (+20.06%).
- CORT TTM revenue is now at all-time high.
Performance
CORT TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
CORT Revenue Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +20.0% | +24.3% | +20.1% |
| 3 y3 years | +36.3% | +77.1% | +56.4% |
| 5 y5 years | +92.0% | +77.1% | +56.4% |
CORT Revenue Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +31.8% | at high | +94.8% | at high | +71.8% |
| 5 y | 5-year | at high | +57.4% | at high | +129.8% | at high | +105.1% |
| alltime | all time | at high | >+9999.0% | at high | >+9999.0% | at high | >+9999.0% |
Corcept Therapeutics Incorporated Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $182.55 M(+11.4%) | $628.55 M(+10.3%) |
| Jun 2024 | - | $163.80 M(+11.6%) | $569.61 M(+8.8%) |
| Mar 2024 | - | $146.81 M(+8.4%) | $523.53 M(+8.5%) |
| Dec 2023 | $482.38 M(+20.0%) | $135.41 M(+9.6%) | $482.38 M(+7.2%) |
| Sep 2023 | - | $123.60 M(+5.0%) | $450.03 M(+5.1%) |
| Jun 2023 | - | $117.72 M(+11.4%) | $428.15 M(+3.5%) |
| Mar 2023 | - | $105.65 M(+2.5%) | $413.82 M(+3.0%) |
| Dec 2022 | $401.86 M(+9.8%) | $103.06 M(+1.3%) | $401.86 M(+1.1%) |
| Sep 2022 | - | $101.73 M(-1.6%) | $397.62 M(+1.4%) |
| Jun 2022 | - | $103.39 M(+10.4%) | $392.03 M(+3.1%) |
| Mar 2022 | - | $93.69 M(-5.2%) | $380.23 M(+3.9%) |
| Dec 2021 | $365.98 M(+3.4%) | $98.82 M(+2.8%) | $365.98 M(+3.7%) |
| Sep 2021 | - | $96.13 M(+5.0%) | $352.89 M(+2.9%) |
| Jun 2021 | - | $91.59 M(+15.3%) | $343.09 M(+0.9%) |
| Mar 2021 | - | $79.44 M(-7.3%) | $340.06 M(-3.9%) |
| Dec 2020 | $353.87 M(+15.5%) | $85.73 M(-0.7%) | $353.87 M(-0.6%) |
| Sep 2020 | - | $86.33 M(-2.5%) | $356.03 M(+1.4%) |
| Jun 2020 | - | $88.56 M(-5.0%) | $351.21 M(+4.9%) |
| Mar 2020 | - | $93.25 M(+6.1%) | $334.90 M(+9.3%) |
| Dec 2019 | $306.49 M(+22.0%) | $87.89 M(+7.8%) | $306.49 M(+7.4%) |
| Sep 2019 | - | $81.50 M(+12.8%) | $285.42 M(+6.4%) |
| Jun 2019 | - | $72.26 M(+11.5%) | $268.36 M(+3.8%) |
| Mar 2019 | - | $64.83 M(-3.0%) | $258.42 M(+2.9%) |
| Dec 2018 | $251.25 M(+57.8%) | $66.83 M(+3.7%) | $251.25 M(+5.7%) |
| Sep 2018 | - | $64.44 M(+3.4%) | $237.70 M(+10.0%) |
| Jun 2018 | - | $62.31 M(+8.1%) | $216.01 M(+14.1%) |
| Mar 2018 | - | $57.66 M(+8.2%) | $189.26 M(+18.9%) |
| Dec 2017 | $159.20 M | $53.28 M(+24.6%) | $159.20 M(+22.7%) |
| Sep 2017 | - | $42.76 M(+20.3%) | $129.73 M(+19.4%) |
| Jun 2017 | - | $35.56 M(+28.8%) | $108.69 M(+17.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2017 | - | $27.60 M(+15.9%) | $92.86 M(+14.2%) |
| Dec 2016 | $81.32 M(+61.7%) | $23.81 M(+9.6%) | $81.32 M(+12.2%) |
| Sep 2016 | - | $21.73 M(+10.1%) | $72.48 M(+13.2%) |
| Jun 2016 | - | $19.72 M(+22.8%) | $64.01 M(+13.8%) |
| Mar 2016 | - | $16.06 M(+7.3%) | $56.24 M(+11.9%) |
| Dec 2015 | $50.29 M(+89.4%) | $14.97 M(+12.9%) | $50.29 M(+13.4%) |
| Sep 2015 | - | $13.26 M(+10.9%) | $44.33 M(+15.6%) |
| Jun 2015 | - | $11.96 M(+18.4%) | $38.35 M(+18.9%) |
| Mar 2015 | - | $10.10 M(+12.1%) | $32.25 M(+21.5%) |
| Dec 2014 | $26.55 M(+156.4%) | $9.01 M(+23.8%) | $26.55 M(+22.6%) |
| Sep 2014 | - | $7.28 M(+24.5%) | $21.65 M(+27.3%) |
| Jun 2014 | - | $5.85 M(+32.8%) | $17.00 M(+30.4%) |
| Mar 2014 | - | $4.41 M(+7.0%) | $13.04 M(+26.0%) |
| Dec 2013 | $10.36 M(+213.2%) | $4.12 M(+56.2%) | $10.36 M(+35.9%) |
| Sep 2013 | - | $2.63 M(+39.3%) | $7.62 M(+26.1%) |
| Jun 2013 | - | $1.89 M(+10.1%) | $6.04 M(+20.2%) |
| Mar 2013 | - | $1.72 M(+24.7%) | $5.02 M(+51.9%) |
| Dec 2012 | $3.31 M(>+9900.0%) | $1.38 M(+30.5%) | $3.31 M(+71.3%) |
| Sep 2012 | - | $1.05 M(+20.6%) | $1.93 M(+120.6%) |
| Jun 2012 | - | $875.00 K(>+9900.0%) | $875.00 K(+266.1%) |
| Dec 2009 | $29.00 K(-86.1%) | - | - |
| Jun 2009 | - | $6000.00(-75.0%) | $239.00 K(+2.6%) |
| Mar 2009 | - | $24.00 K(-83.2%) | $233.00 K(+11.5%) |
| Dec 2008 | $209.00 K(-56.6%) | $143.00 K(+116.7%) | $209.00 K(+216.7%) |
| Sep 2008 | - | $66.00 K(-82.4%) | $66.00 K(-88.1%) |
| Dec 2007 | $482.00 K(+63.9%) | - | - |
| Jun 2007 | - | $374.00 K(+246.3%) | $555.00 K(+97.5%) |
| Mar 2007 | - | $108.00 K(+47.9%) | $281.00 K(-4.4%) |
| Dec 2006 | $294.00 K | $73.00 K(-27.0%) | $294.00 K(+33.0%) |
| Jun 2006 | - | $100.00 K(-17.4%) | $221.00 K(+82.6%) |
| Mar 2006 | - | $121.00 K | $121.00 K |
FAQ
- What is Corcept Therapeutics Incorporated annual revenue?
- What is the all time high annual revenue for Corcept Therapeutics Incorporated?
- What is Corcept Therapeutics Incorporated annual revenue year-on-year change?
- What is Corcept Therapeutics Incorporated quarterly revenue?
- What is the all time high quarterly revenue for Corcept Therapeutics Incorporated?
- What is Corcept Therapeutics Incorporated quarterly revenue year-on-year change?
- What is Corcept Therapeutics Incorporated TTM revenue?
- What is the all time high TTM revenue for Corcept Therapeutics Incorporated?
- What is Corcept Therapeutics Incorporated TTM revenue year-on-year change?
What is Corcept Therapeutics Incorporated annual revenue?
The current annual revenue of CORT is $482.38 M
What is the all time high annual revenue for Corcept Therapeutics Incorporated?
Corcept Therapeutics Incorporated all-time high annual revenue is $482.38 M
What is Corcept Therapeutics Incorporated annual revenue year-on-year change?
Over the past year, CORT annual revenue has changed by +$80.52 M (+20.04%)
What is Corcept Therapeutics Incorporated quarterly revenue?
The current quarterly revenue of CORT is $182.55 M
What is the all time high quarterly revenue for Corcept Therapeutics Incorporated?
Corcept Therapeutics Incorporated all-time high quarterly revenue is $182.55 M
What is Corcept Therapeutics Incorporated quarterly revenue year-on-year change?
Over the past year, CORT quarterly revenue has changed by +$35.74 M (+24.34%)
What is Corcept Therapeutics Incorporated TTM revenue?
The current TTM revenue of CORT is $628.55 M
What is the all time high TTM revenue for Corcept Therapeutics Incorporated?
Corcept Therapeutics Incorporated all-time high TTM revenue is $628.55 M
What is Corcept Therapeutics Incorporated TTM revenue year-on-year change?
Over the past year, CORT TTM revenue has changed by +$105.03 M (+20.06%)